BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 28871623)

  • 1. Clinical course of patients with symptomatic isolated superficial vein thrombosis: the ICARO follow-up study.
    Barco S; Pomero F; Di Minno MND; Tamborini Permunian E; Malato A; Pasca S; Barillari G; Fenoglio L; Siragusa S; Di Minno G; Ageno W; Dentali F
    J Thromb Haemost; 2017 Nov; 15(11):2176-2183. PubMed ID: 28871623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term risk of venous thromboembolism recurrence after isolated superficial vein thrombosis.
    Galanaud JP; Sevestre MA; Pernod G; Kahn SR; Genty C; Terrisse H; Brisot D; Gillet JL; Quéré I; Bosson JL
    J Thromb Haemost; 2017 Jun; 15(6):1123-1131. PubMed ID: 28317330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical course of isolated distal deep vein thrombosis in patients with active cancer: a multicenter cohort study.
    Dentali F; Pegoraro S; Barco S; di Minno MND; Mastroiacovo D; Pomero F; Lodigiani C; Bagna F; Sartori M; Barillari G; Mumoli N; Napolitano M; Passamonti SM; Benedetti R; Ageno W; Di Nisio M
    J Thromb Haemost; 2017 Sep; 15(9):1757-1763. PubMed ID: 28639418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival and recurrent venous thromboembolism in patients with first proximal or isolated distal deep vein thrombosis and no pulmonary embolism.
    Barco S; Corti M; Trinchero A; Picchi C; Ambaglio C; Konstantinides SV; Dentali F; Barone M
    J Thromb Haemost; 2017 Jul; 15(7):1436-1442. PubMed ID: 28439954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Silent pulmonary embolism in patients with proximal deep vein thrombosis in the lower limbs.
    Tzoran I; Saharov G; Brenner B; Delsart D; Román P; Visoná A; Jiménez D; Monreal M;
    J Thromb Haemost; 2012 Apr; 10(4):564-71. PubMed ID: 22288520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Superficial vein thrombosis and recurrent venous thromboembolism: a pooled analysis of two observational studies.
    Galanaud JP; Bosson JL; Genty C; Presles E; Cucherat M; Sevestre MA; Quere I; Decousus H; Leizorovicz A
    J Thromb Haemost; 2012 Jun; 10(6):1004-11. PubMed ID: 22429908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of deep vein thrombosis and pulmonary embolism in patients with superficial vein thrombosis: a systematic review and meta-analysis.
    Di Minno MN; Ambrosino P; Ambrosini F; Tremoli E; Di Minno G; Dentali F
    J Thromb Haemost; 2016 May; 14(5):964-72. PubMed ID: 26845754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence of venous thromboembolism, recurrence, and bleeding after isolated superficial vein thrombosis: findings from the Venous Thrombosis Registry in Østfold Hospital.
    Jørgensen CT; Brækkan SK; Førsund E; Pettersen HH; Tjønnfjord E; Ghanima W; Tavoly M
    J Thromb Haemost; 2024 Feb; 22(2):526-533. PubMed ID: 37913911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of anatomical location of lower limb venous thrombus on the risk of subsequent cancer.
    Galanaud JP; Arnoult AC; Sevestre MA; Genty C; Bonaldi M; Guyard A; Giordana P; Pichot O; Colonna M; Quéré I; Bosson JL;
    Thromb Haemost; 2014 Dec; 112(6):1129-36. PubMed ID: 25104514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized double-blind study of low-molecular-weight heparin (parnaparin) for superficial vein thrombosis: STEFLUX (Superficial ThromboEmbolism and Fluxum).
    Cosmi B; Filippini M; Tonti D; Avruscio G; Ghirarduzzi A; Bucherini E; Camporese G; Imberti D; Palareti G;
    J Thromb Haemost; 2012 Jun; 10(6):1026-35. PubMed ID: 22487001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determinants of Late Venous Thromboembolic Events After Acute Isolated Superficial Vein Thrombosis in Daily Practice: 12 Month Results of the INSIGHTS-SVT Study.
    Rabe E; Hoffmann U; Schimke A; Heinken A; Langer F; Noppeney T; Pittrow D; Klotsche J; Gerlach HE; Bauersachs R;
    Eur J Vasc Endovasc Surg; 2023 Nov; 66(5):697-704. PubMed ID: 37573936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management and Outcomes of Patients with Isolated Superficial Vein Thrombosis under Real Life Conditions (INSIGHTS-SVT).
    Bauersachs R; Gerlach HE; Heinken A; Hoffmann U; Langer F; Noppeney T; Pittrow D; Klotsche J; Rabe E
    Eur J Vasc Endovasc Surg; 2021 Aug; 62(2):241-249. PubMed ID: 34210599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The long-term recurrence risk of patients with unprovoked venous thromboembolism: an observational cohort study.
    Kyrle PA; Kammer M; Eischer L; Weltermann A; Minar E; Hirschl M; Heinze G; Eichinger S
    J Thromb Haemost; 2016 Dec; 14(12):2402-2409. PubMed ID: 27696701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic Significance of Concomitant Superficial Vein Thrombosis in Patients with Deep Vein Thrombosis of the Lower Limbs.
    Dubois-Silva Á; Barbagelata-López C; Piñeiro-Parga P; Francisco I; Falgá C; Tirado R; Suriñach JM; Vela JR; Mella C; Quere I; Siniscalchi C; Monreal M;
    Thromb Haemost; 2021 Dec; 121(12):1650-1659. PubMed ID: 33677826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A systematic review and meta-analysis for the association between duration of anticoagulation therapy and the risk of venous thromboembolism in patients with lower limb superficial venous thrombosis.
    Lobastov K; Dubar E; Schastlivtsev I; Bargandzhiya A
    J Vasc Surg Venous Lymphat Disord; 2024 Mar; 12(2):101726. PubMed ID: 38008180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of deep vein thrombosis in patients presenting with acute symptomatic pulmonary embolism.
    Jiménez D; Aujesky D; Díaz G; Monreal M; Otero R; Martí D; Marín E; Aracil E; Sueiro A; Yusen RD;
    Am J Respir Crit Care Med; 2010 May; 181(9):983-91. PubMed ID: 20110556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of 3 and 6 months of oral anticoagulant therapy after a first episode of proximal deep vein thrombosis or pulmonary embolism and comparison of 6 and 12 weeks of therapy after isolated calf deep vein thrombosis. Pinede L, Ninet J, Duhaut P et al for the Investigators of the 'Durée Optimale du Traitement Antivitamines K' (DOTAVK) study. Circulation 2001; 103: 2453-60.
    Anand SS
    Vasc Med; 2001 Nov; 6(4):269-70. PubMed ID: 11958396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic Anticoagulation for Isolated Calf Deep Vein Thrombosis.
    Utter GH; Dhillon TS; Salcedo ES; Shouldice DJ; Reynolds CL; Humphries MD; White RH
    JAMA Surg; 2016 Sep; 151(9):e161770. PubMed ID: 27437827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term outcomes of isolated superficial vein thrombosis in patients with active cancer.
    Galanaud JP; Blaise S; Sevestre MA; Terrisse H; Pernod G; Gaillard C; Genty C; Monreal M; Rabah Y; Kahn SR; Quéré I; Bosson JL;
    Thromb Res; 2018 Nov; 171():179-186. PubMed ID: 29789147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deep vein thrombosis and/or pulmonary embolism concurrent with superficial vein thrombosis of the legs: cross-sectional single center study of prevalence and risk factors.
    Hirmerova J; Seidlerova J; Subrt I
    Int Angiol; 2013 Aug; 32(4):410-6. PubMed ID: 23822944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.